Budget Impact of Treatment-Free Remission in Treating Chronic-Phase Philadelphia-Positive Chronic Myeloid Leukemia in Lebanon

PURPOSE: Chronic myeloid leukemia (CML) ranks second in terms of disease-related health care expenditures at the Lebanese Ministry of Public Health (MoPH) after breast cancer. With the introduction of tyrosine kinase inhibitors (TKIs), survival of patients with CML has dramatically improved and appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Elias, Fadia, Gebran, Anthony, Said, Christina, Beker, Russell V., Ammar, Walid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613662/
https://www.ncbi.nlm.nih.gov/pubmed/31166826
http://dx.doi.org/10.1200/JGO.19.00012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613662/
https://www.ncbi.nlm.nih.gov/pubmed/31166826
http://dx.doi.org/10.1200/JGO.19.00012

Ejemplares similares